Nasopharyngitis and drugs of ingredients of metformin hydrochloride; pioglitazone hydrochloride (a real world drug study)


Summary:

Nasopharyngitis is found among people who take drugs with ingredients of metformin hydrochloride; pioglitazone hydrochloride, especially for people who are male, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 1,842 people who have side effects when taking drugs with ingredients of metformin hydrochloride; pioglitazone hydrochloride from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Actoplus met, Pioglitazone hydrochloride and metformin hydrochloride.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Aug, 21, 2026

1,842 people reported to have side effects when taking drugs with ingredients of metformin hydrochloride; pioglitazone hydrochloride.
Among them, 20 people (1.09%) have Nasopharyngitis


What is Nasopharyngitis?

Nasopharyngitis (inflammation of the nasopharynx) is found to be associated with 2,431 drugs and 2,245 conditions by eHealthMe. Check the latest studies of Nasopharyngitis.

Number of reports submitted per year:

Could drugs with ingredients of metformin hydrochloride; pioglitazone hydrochloride cause Nasopharyngitis?

Gender of people who have Nasopharyngitis when taking drugs with ingredients of metformin hydrochloride; pioglitazone hydrochloride *:

  • female: 35 %
  • male: 65 %

Age of people who have Nasopharyngitis when taking drugs with ingredients of metformin hydrochloride; pioglitazone hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.88 %
  • 40-49: 17.65 %
  • 50-59: 23.53 %
  • 60+: 52.94 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Depression: 3 people, 15.00%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.00%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
  4. Pityriasis Rubra Pilaris (reddish-orange colour scaling patches with well defined borders): 1 person, 5.00%
  5. Itching: 1 person, 5.00%
  6. Interstitial Lung Disease: 1 person, 5.00%
  7. Insomnia (sleeplessness): 1 person, 5.00%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.00%
  9. High Blood Pressure: 1 person, 5.00%
  10. Hepatitis C: 1 person, 5.00%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Apidra: 6 people, 30.00%
  2. Levemir: 6 people, 30.00%
  3. Byetta: 5 people, 25.00%
  4. Tresiba: 5 people, 25.00%
  5. Gliclazide: 5 people, 25.00%
  6. Atorvastatin Calcium: 4 people, 20.00%
  7. Clopidogrel Bisulfate: 4 people, 20.00%
  8. Metformin Hydrochloride: 3 people, 15.00%
  9. Cetirizine Hydrochloride: 3 people, 15.00%
  10. Prednisone: 3 people, 15.00%

Other side effects people have besides Nasopharyngitis *:

You may use this to check any potential undetected side effects.

  1. Nausea (feeling of having an urge to vomit): 11 people, 55.00%
  2. Dizziness: 8 people, 40.00%
  3. Blood Glucose Increased: 7 people, 35.00%
  4. Headache (pain in head): 6 people, 30.00%
  5. Rhinorrhea (watery mucus discharge from the nose): 6 people, 30.00%
  6. Blood Pressure Systolic Increased: 5 people, 25.00%
  7. Hyperhidrosis (abnormally increased sweating): 5 people, 25.00%
  8. Malaise (a feeling of general discomfort or uneasiness): 5 people, 25.00%
  9. Pain: 5 people, 25.00%
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 25.00%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of metformin hydrochloride; pioglitazone hydrochloride, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride; pioglitazone hydrochloride. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: